Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_assertion type Assertion NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_head.
- NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_provenance.
- NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_assertion evidence source_evidence_literature NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_provenance.
- NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_assertion SIO_000772 18480833 NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_provenance.
- NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_assertion wasDerivedFrom befree-20140225 NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_provenance.
- NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_assertion wasGeneratedBy ECO_0000203 NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_provenance.